SCHEMBL3639047

SCHEMBL3639047

CC(C)(C)c1n[nH]cc1-c1ccc(Br)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ATM Q13315 2/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ METAP2 P50579 1/20 0.34
▸ IKBKB O14920 1/20 0.34
▸ CHUK O15111 1/20 0.34
▸ PLK4 O00444 1/20 0.34
▸ AURKA O14965 1/20 0.34
▸ JAK2 O60674 1/20 0.34
▸ LCK P06239 1/20 0.34
▸ CDK1 P06493 1/20 0.34
▸ CSF1R P07333 1/20 0.34
▸ LYN P07948 1/20 0.34
▸ FGFR1 P11362 1/20 0.34
▸ SRC P12931 1/20 0.34
▸ PRKACA P17612 1/20 0.34
▸ RPS6KB1 P23443 1/20 0.34
▸ CDK2 P24941 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27152986 0.77 RXRA (0.45) TP53MAPK1
SCHEMBL1978092 0.76 SMN1; SMN2 (0.43) NPC1RAB9ASMN1; SMN2ATMMETAP2
SCHEMBL27149405 0.74 KDM4E (0.46) NPC1RAB9ASMN1; SMN2MAPTMEN1
SCHEMBL1384288 0.72 KMT2A (0.38) NPC1RAB9ASMN1; SMN2ATMMETAP2
SCHEMBL19656316 0.72 MAPT (0.41) NPC1RAB9ASMN1; SMN2ATMMETAP2
SCHEMBL27791447 0.70 SLC22A12 (0.36) ATML3MBTL1SLC22A12MAPTKMT2A
SCHEMBL2186233 0.70 HPGD (0.35) —
SCHEMBL1128951 0.69 ALDH1A1 (0.50) NPC1RAB9ASMN1; SMN2PLK4AURKA
SCHEMBL1129154 0.69 ALDH1A1 (0.50) NPC1RAB9ASMN1; SMN2PLK4AURKA
SCHEMBL21805114 0.69 DYRK1A (0.45) ROCK1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2176256-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES AstraZeneca AB (SE) 2010-04-21 — — EP disclosed
WO-2009007751-A2 TRISUBSTITUTED PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PROLIFERATIVE DISEASES ASTRAZENECA AB (SE) 2009-01-15 — — WO disclosed
Send feedback